CELU Celularity Inc.
$1.41▼ -1.74%
Healthcare
Other
After hours
$1.42▲ +0.71%
Sep 11, 7:43 PM ET
Volume 96.7K
Avg Volume (10D) 24.31M
Key Metrics & Fundamentals
Market Cap
$40.81M
P/E Ratio
–
Div Yield
–%
52W Range
0.56 - 2.55
% vs 50 MA
48.84%
% vs 200 MA
24.35%
RSI-14
55.5
MACD Histogram
-0.0200
Beta (1Y vs SPY)
1.91
Free Cash Flow
-$5.10M
Gross Rev
$4.10M
Gross Profit
-$3.27M
EBITDA
-$20.81M
COGS
$7.37M
Operating Exp
$18.79M
Operating Income
-$22.06M
EBIT
-$22.06M
Pretax Income
-$24.36M
Net Income
-$24.36M
Price & Volume History
Loading chart…
Recent News
BC-Most Active Stocks
Associated Press · Aug 27, 2026 2:30 PM
Celularity Signs U.S. Manufacturing Collaboration With Potential $300 Million Purchase Opportunity
InvestorsHub · Aug 27, 2026 2:27 PM
Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform
Business Wire · Aug 27, 2026 1:00 PM
Celularity Provides Update Regarding Nasdaq Listing Compliance
GlobeNewswire · Aug 25, 2026 11:59 PM
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
GlobeNewswire · Aug 20, 2026 8:05 PM
NexGel Files to Register 15.25 Million Shares From Note Conversions
MT Newswires · Aug 20, 2026 5:35 PM
NEXGEL Q2 Revenue Reaches $3.69 Million as BioNX Integration Faces Slower Ramp
InvestorsHub · Aug 17, 2026 2:54 PM
NEXGEL Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 17, 2026 12:00 PM
Celularity Appoints Chief Operating Officer
MT Newswires · Jun 26, 2026 9:49 AM
Financial Overview - Income Statement
Quarterly
Dec 2025
See CELU's money flow as a full page
Social Sentiment
Avg +0.60 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.